Prothena Corp PLC (PRTA) Stock Price, Quote, News & History

PRTANASDAQ
$9.56
-0.13-1.29%
Last update: Sep 3, 3:23 PM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-60.05M
Investing Cash Flow (TTM)
-662.00K
Financing Cash Flow (TTM)
-22.53M
Free Cash Flow (TTM)
-60.71M
Capital Expenditure (TTM)
-662.00K
Net Change in Cash (TTM)
-83.24M

Analyst Trends and Forecast

0
0
0
0
May
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.6
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$216.00M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
9.52
PB Ratio (TTM)
1.73
Earnings Yield % (TTM)
-8.47%
Earnings Yield % (FWD)
-5.68%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.59

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$288.19M
Debt to Equity
0.02
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$9.77
Close
-
Volume / Avg.
170.54K / 518.94K
Day Range
$9.51 - $9.78
52 Wk Range
7.73 - 11.80
Market Cap
$500.50M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
59
Short Interest
19.58%
Days to Cover
19.56

About

Sector
Health Care
Industry
Biotechnology
Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amy...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Prothena Corp (PRTA) stock?

A

You can purchase shares of Prothena Corp (NASDAQ:PRTA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Prothena Corp (PRTA) competitors?

Q

What is the forecast, or price target, for Prothena Corp (PRTA) stock?

A

Prothena Corp has a consensus price target of $27.82.

Q

What is the current price for Prothena Corp (PRTA)?

A

The stock price for Prothena Corp (NASDAQ: PRTA) is $9.56 last updated September 3, 2026 at 3:23 PM EDT.

Q

Does Prothena Corp (PRTA) pay a dividend?

A

There are no upcoming dividends for Prothena Corp.

Q

When is Prothena Corp (NASDAQ:PRTA) reporting earnings?

A

Prothena Corp does not have any upcoming earnings scheduled.

Q

Is Prothena Corp (PRTA) going to split?

A

There is no upcoming split for Prothena Corp.

Q

What sector and industry does Prothena Corp (PRTA) operate in?

A

Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.